After a strong FY24, Aurobindo Pharma Ltd. is expected to post a moderate 10% YoY earnings growth in FY25, partly due to: operational losses from the PEN-G product and disrupted production at Eugia III caused by regulatory issues. With the above issues largely behind, we expect Aurobindo Pharma to witness an uptrend in earnings growth, led by-

BloombergQuint | Latest and Live Business, Market, Political and Economy News

12.05.2025

Navin Fluorine Q4 Results Review: ICICI Securities Downgrades The Stock To 'Hold', Cuts Target Price

Navin Fluorine International Ltd.’s business is shaping up well with visible scaling up of pharma contract development manufacturing organisation and multiple latestage contracts in sight. Agro-chemicals’ intermediate capacities are ramping up with new product campaigns rising. Refgas has capacity expansion in clean R-32, and supply contract for HFO. And now, Navin Fluorine is foraying into advance materials with initial capacities of two-phase immersion cooling fluid

BloombergQuint | Latest and Live Business, Market, Political and Economy News

12.05.2025

Garden Reach Shipbuilders Q4 Results: Date, Dividend Details And More

Garden Reach Shipbuilders and Engineers Ltd. (GRSE) is scheduled to announce its financial results for the fourth quarter and the full fiscal ended March 31, 2025, this week. The shipbuilding company confirmed the date of the upcoming earnings release in a stock exchange filing. The Kolkata-based company is a public sector undertaking (PSU), which operates under the Ministry of Defence.

BloombergQuint | Latest and Live Business, Market, Political and Economy News

12.05.2025

Dalal Street Rallies As India-Pakistan Ceasefire Boosts Investor Sentiment

Indian equity markets surged on Monday morning, buoyed by improved investor sentiment following a significant de-escalation in tensions between India and Pakistan. This development, combined with encouraging signals from the ongoing US-China trade negotiations, lifting the benchmark indices nearly 3%.

home›BloombergQuint | Latest and Live Business, Market, Political and Economy News

BloombergQuint | Latest and Live Business, Market, Political and Economy News

Economy

Aurobindo Pharma Gets 'Buy' Upgrade From Motilal Oswal On Attractive Valuations

Navin Fluorine Q4 Results Review: ICICI Securities Downgrades The Stock To 'Hold', Cuts Target Price

Garden Reach Shipbuilders Q4 Results: Date, Dividend Details And More

Dalal Street Rallies As India-Pakistan Ceasefire Boosts Investor Sentiment

home
›
BloombergQuint | Latest and Live Business, Market, Political and Economy News